The effect of dioxidovanadium complex (V) on hepatic function in streptozotocin-induced diabetic rats
Sibiya, S; Msibi, B; Khathi, A; Sibiya, N; Booysen, I; Ngubane, P
HERO ID
6308101
Reference Type
Journal Article
Year
2019
Language
English
PMID
| HERO ID | 6308101 |
|---|---|
| In Press | No |
| Year | 2019 |
| Title | The effect of dioxidovanadium complex (V) on hepatic function in streptozotocin-induced diabetic rats |
| Authors | Sibiya, S; Msibi, B; Khathi, A; Sibiya, N; Booysen, I; Ngubane, P |
| Journal | Canadian Journal of Physiology and Pharmacology |
| Volume | 97 |
| Issue | 12 |
| Page Numbers | 1169-1175 |
| Abstract | Diabetics are susceptible to hepatic dysfunction risks due to hyperglycaemia and insulin therapy. Conventional diabetes treatments improve glycaemic control; however, hepatic hazards associated with these agents remains a challenge. Accordingly, this study sought to investigate the effect of a dioxidovanadium complex (V) on the hepatic function in streptozotocin-induced diabetic rats. Sprague-Dawley rats (240-250 g) were divided into 4 groups (n = 6): nondiabetic control, diabetic control, insulin-treated, and vanadium complex groups. The dioxidovanadium (10, 20, and 40 mg/kg) was administered twice every 2nd day for 5 weeks and blood glucose concentration was monitored weekly. At the end of the experimental period, all the experimental groups were sacrificed, and then the lipid profile, liver superoxide dismutase, glutathione peroxidase and malondialdehyde, plasma alanine aminotransferase and aspartate aminotransferase, and C-reactive protein (CRP) concentration were measured. The administration of dioxidovanadium significantly alleviated hyperglycaemia with concomitant attenuation in oxidative stress as evidenced by reduced malondialdehyde concentrations. Furthermore, vanadium complex abolished diabetes-induced dyslipidaemia. Lastly, vanadium complex administration attenuated the increase in alanine aminotransferase, aspartate aminotransferase, and plasma C-reactive protein. These findings suggest that this metallo-compound (dioxidovanadium) may ameliorate liver dysfunction often observed in diabetes. |
| Doi | 10.1139/cjpp-2019-0369 |
| Pmid | 31491333 |
| Wosid | WOS:000497746400008 |
| Is Certified Translation | No |
| Dupe Override | No |
| Is Public | Yes |
| Language Text | English |
| Keyword | hyperglycaemia; oxidative stress; liver dysfunction; C-reactive protein; liver function marker enzymes |